Skip to main content

Published locations for FDA issues CRL for proposed biosimilar rituximab

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA issues CRL for proposed biosimilar rituximab

User login

  • Reset your password
  • /content/fda-issues-crl-proposed-biosimilar-rituximab
  • /hematology-oncology/article/184973/lymphoma-plasma-cell-disorders/fda-issues-crl-proposed-biosimilar
  • /hematologytimes/article/184973/lymphoma-plasma-cell-disorders/fda-issues-crl-proposed-biosimilar
  • /b-cell-lymphoma-icymi/article/184973/lymphoma-plasma-cell-disorders/fda-issues-crl-proposed